-
Article
Severe renal insufficiency is not an absolute pitfall to autologous stem cell transplantation with BeEAM (bendamustine, etoposide, cytarabine, melphalan) conditioning regimen
-
Article
Natural killer cells in acute myeloid leukemia patients: from phenotype to transcriptomic analysis
Chemotherapies allow complete remission in more than 50 % of patients with acute myeloid leukemia (AML), however, with frequent relapse. This suggests that residual leukemic cells may escape to chemotherapy an...
-
Article
Open AccessAldehyde dehydrogenases inhibition eradicates leukemia stem cells while sparing normal progenitors
The vast majority of patients with acute myeloid leukemia (AML) achieve complete remission (CR) after standard induction chemotherapy. However, the majority subsequently relapse and die of the disease. A leuke...
-
Article
Full but impaired activation of innate immunity effectors and virus-specific T cells during CMV and EBV disease following cord blood transplantation
-
Article
Sepsis and neutropenia in hematological malignancies
-
Article
Clinical evidence implicating gamma-delta T cells in EBV control following cord blood transplantation
-
Article
Recurrent superior vena cava syndrome caused by IgD multiple myeloma